106 related articles for article (PubMed ID: 4325410)
1. Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide.
Kusama M; Sakauchi N; Kumaoka S
Metabolism; 1971 Jun; 20(6):590-6. PubMed ID: 4325410
[No Abstract] [Full Text] [Related]
2. [Blood concentration and urinary excretion rate following intramuscular injection of triamcinolone acetonide].
Kusama M; Sakauchi N; Kumaoka S
Nihon Naibunpi Gakkai Zasshi; 1970 Sep; 46(6):654-8. PubMed ID: 5528352
[No Abstract] [Full Text] [Related]
3. [Course of plasma- and urine level after intramuscular application of 40, 80 and 120 mg of triamcinolone-acetonide].
Zicha L
Arzneimittelforschung; 1969 Mar; 19(3):340-2. PubMed ID: 5818787
[No Abstract] [Full Text] [Related]
4. Simultaneous determination of triamcinolone acetonide and hydrocortisone in human plasma by high-performance liquid chromatography.
Döppenschmitt SA; Scheidel B; Harrison F; Surmann JP
J Chromatogr B Biomed Appl; 1996 Jun; 682(1):79-88. PubMed ID: 8832428
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of systemic absorption of intraturbinally injected triamcinolone.
Mabry RL
Otolaryngol Head Neck Surg; 1981; 89(2):268-70. PubMed ID: 6787524
[TBL] [Abstract][Full Text] [Related]
6. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
Schott S; Schnauder G; Müssig K
Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis.
Siegel LB; Alloway JA; Nashel DJ
J Rheumatol; 1994 Jul; 21(7):1325-7. PubMed ID: 7966077
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.
Soma LR; Uboh CE; You Y; Guan F; Boston RC
Am J Vet Res; 2011 Sep; 72(9):1234-42. PubMed ID: 21879982
[TBL] [Abstract][Full Text] [Related]
9. Additional studies on triamcinolone acetonide use and misuse in sports: Elimination profile after intranasal and high-dose intramuscular administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Steroids; 2019 Nov; 151():108464. PubMed ID: 31344406
[TBL] [Abstract][Full Text] [Related]
10. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Yolcu Ü; Ilhan A
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):1. PubMed ID: 25635966
[No Abstract] [Full Text] [Related]
11. Corticosteroid and Cortisol Serum Levels Following Intra-articular Triamcinolone Acetonide Lumbar Facet Joint Injections.
Dickson RR; Reid JM; Nicholson WT; Lamer TJ; Hooten WM
Pain Pract; 2018 Sep; 18(7):864-870. PubMed ID: 29436106
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-acting parenteral corticosteroids on adrenal function.
Mikhail GR; Livingood CS; Mellinger RC; Paige TN; Salyer HL
Arch Dermatol; 1969 Sep; 100(3):263-8. PubMed ID: 4241801
[No Abstract] [Full Text] [Related]
13. [Endogenous cortisol levels after intrathecal injection of triamicinolone acetonide in patients with neurological disease (author's transl)].
Neu I; Reusche E; Rodiek S
Dtsch Med Wochenschr; 1978 Sep; 103(35):1368-70. PubMed ID: 581070
[TBL] [Abstract][Full Text] [Related]
14. Long-term intramuscular administration of triamcinolone acetonide.
Mikhail GR; Sweet LC; Mellinger RC
Arch Dermatol; 1977 Jan; 113(1):111. PubMed ID: 831617
[No Abstract] [Full Text] [Related]
15. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function.
Mikhail GR; Sweet LC; Mellinger RC
Ann Allergy; 1973 Jul; 31(7):337-43. PubMed ID: 4352151
[No Abstract] [Full Text] [Related]
16. Triamcinolone hexacetonide for intraarticular and intramuscular therapy.
Clemmesen S
Acta Rheumatol Scand; 1971; 17(4):273-8. PubMed ID: 5316553
[No Abstract] [Full Text] [Related]
17. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Kaderli B; Kivanc SA; Inan UU; Ersoy C; Yucel AA; Yilmaz S; Avci R
Eur Rev Med Pharmacol Sci; 2014; 18(18):2609-14. PubMed ID: 25317793
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of triamcinolone acetonide-21-phosphate in dogs, monkeys, and rats.
Kripalani KJ; Cohen AI; Weliky I; Schreiber EC
J Pharm Sci; 1975 Aug; 64(8):1351-9. PubMed ID: 807712
[TBL] [Abstract][Full Text] [Related]
19. Duration of action of depot-corticosteroids. II. Triamcinolone acetonide and triamcinolone diacetate.
Frey H; Norman N
Eur J Clin Pharmacol; 1971 Sep; 3(4):229-31. PubMed ID: 5151305
[No Abstract] [Full Text] [Related]
20. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
Taylor KS; Malkinson FD; Gak C
Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
